Assessment of Socio Demographic Characteristics on Uptake of Tuberculosis Screening by Community Members in Meru County, Kenya

The trend in tuberculosis in Kenya is worrying. TB is the fourth leading cause of death. In 2015 81,518 cases of TB were identified and treated. The Kenya prevalence survey of 2015-2016 found that estimated prevalence is 558/100,000 way above the WHO estimate of 233/100,000. The objective of the study was to determine the effect of socio- demographics characteristics on tuberculosis screening among community members in Tigania East of Meru County. The study design used was cross-sectional survey and targeted 440 household drawn from the five wards randomly and proportionately selected. Key informant interviews and focus group discussions were used to collect qualitative data. Qualitative data was analysed thematically. Quantitative data was analysed using descriptive statistics and inferential statistics using SPSS version 26. The study found out that there were statistically significant association between TB screening and religion (X2 =13.103, df 3; p value=0.004,), monthly income (X2 =14.970, df 6; p value=0.020. The study concluded that religion and monthly income of community members of Tigania East were associated with TB screening. Keywords; Socio demographic, Uptake of TB screening, Community members. DOI: 10.7176/JBAH/10-22-05 Publication date: November 30th 202

The Structured Operational Research and Training Initiative (SORT IT), second workshop using the national tuberculosis routinely collected program data

No Abstrac

Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients?

The words 'defaulter', 'suspect' and 'control' have been part of the language of tuberculosis (TB) services for many decades, and they continue to be used in international guidelines and in published literature. From a patient perspective, it is our opinion that these terms are at best inappropriate, coercive and disempowering, and at worst they could be perceived as judgmental and criminalising, tending to place the blame of the disease or responsibility for adverse treatment outcomes on one side-that of the patients. In this article, which brings together a wide range of authors and institutions from Africa, Asia, Latin America, Europe and the Pacific, we discuss the use of the words 'defaulter', 'suspect' and 'control' and argue why it is detrimental to continue using them in the context of TB. We propose that 'defaulter' be replaced with 'person lost to follow-up'; that 'TB suspect' be replaced by 'person with presumptive TB' or 'person to be evaluated for TB'; and that the term 'control' be replaced with 'prevention and care' or simply deleted. These terms are non-judgmental and patient-centred. We appeal to the global Stop TB Partnership to lead discussions on this issue and to make concrete steps towards changing the current paradigm

Mobile phones in the diffusion of knowledge and persistence in inclusive human development in Sub-Saharan Africa

The success of inclusive development strategies in the post-2015 sustainable development agenda depends substantially on the adoption of common inclusive development policies among nations. Building on the relevance of a knowledge economy in the post-2015 development agenda, this study models the feasibility of common policies for inclusive human development in Sub-Saharan Africa (SSA). More specifically, we investigate the complementary role of knowledge diffusion in the inclusive benefits of mobile phone penetration in SSA from 2000 to 2012 by employing the Generalised Method of Moments. Knowledge diffusion variables include educational quality, innovation and Internet penetration. The main finding is that inclusive human development is persistently conditional on mobile phones in knowledge diffusion. Moreover, countries with low levels of inclusive human development are catching-up their counterparts with higher development. Policy implications are discussed with particular emphasis on how to leverage common knowledge economy initiatives for inclusive developmen

Evaluation of Selected Pigeonpea (Cajanus cajan (L.) Millsp.) Genotypes for Resistance to Insect Pest Complex in Dry Areas of North Rift Valley, Kenya

Pigeonpea is an important pulse crop that has gained importance in semi-arid tropics, although its yield potential has not been fully realized due to biotic and abiotic stresses that limit its production. Insect pest complex of pod borer (Helicoverpa armigera), sucking bug (Clavigralla tomentosicollis) and pod fly (Melanagromyza cholcosoma) are the major limiting factors to its production causing up to 100% yield loss. The objective of this study was to evaluate resistant genotypes to insect pest complex in dry parts of North Rift Valley Kenya. The study was carried out in three sites (Kenya Agricultural Livestock Research Organization- Marigat, Agricultural Training Centre-Koibatek and Fluorspar-Chepsirei) for one season during long rain of April-November 2014 growing season. Sixteen ICRISAT elite genotypes were evaluated in randomized complete block design (RCBD) with 75cm inter and 25 cm intra spacing. Significant (P≤0.05) differences in grain yield performance, incidence and severity of the insect pests were revealed in all sites. The damage was more severe in Marigat (Pod borer-37.2%, Sucking bug-39.3% and pod fly-5.9%) than ATC- Koibatek (Pod borer-1.9%, Sucking bug-8.4% and pod fly-5.9%) and Fluorspar (Pod borer-3.6%, Sucking bug-6.8% and pod fly-2.9%). Genotypes ICEAPs 00850R, 00902, 01541 and 1154-2 showed potential levels of resistance to the insect pest complex and high yields. Grain yield associated negatively (P≤0.05) with pod borer and sucking bug damage correlated non-significantly with pod fly damage. The potential genotypes identified in this study need to be further evaluated in two seasons and in other multi-locations to validate these findings to be used in breeding

CXCR4/CXCL12 Participate in Extravasation of Metastasizing Breast Cancer Cells within the Liver in a Rat Model

INTRODUCTION: Organ-specific composition of extracellular matrix proteins (ECM) is a determinant of metastatic host organ involvement. The chemokine CXCL12 and its receptor CXCR4 play important roles in the colonization of human breast cancer cells to their metastatic target organs. In this study, we investigated the effects of chemokine stimulation on adhesion and migration of different human breast cancer cell lines in vivo and in vitro with particular focus on the liver as a major metastatic site in breast cancer. METHODS: Time lapse microscopy, in vitro adhesion and migration assays were performed under CXCL12 stimulation. Activation of small GTPases showed chemokine receptor signalling dependence from ECM components. The initial events of hepatic colonisation of MDA-MB-231 and MDA-MB-468 cells were investigated by intravital microscopy of the liver in a rat model and under shRNA inhibition of CXCR4. RESULTS: In vitro, stimulation with CXCL12 induced increased chemotactic cell motility (p,0.05). This effect was dependent on adhesive substrates (type I collagen, fibronectin and laminin) and induced different responses in small GTPases, such as RhoA and Rac-1 activation, and changes in cell morphology. In addition, binding to various ECM components caused redistribution of chemokine receptors at tumour cell surfaces. In vivo, blocking CXCR4 decreased extravasation of highly metastatic MDA-MB-231 cells (p < 0.05), but initial cell adhesion within the liver sinusoids was not affected. In contrast, the less metastatic MDA-MB-468 cells showed reduced cell adhesion but similar migration within the hepatic microcirculation. CONCLUSION: Chemokine-induced extravasation of breast cancer cells along specific ECM components appears to be an important regulator but not a rate-limiting factor of their metastatic organ colonization.Claudia Wendel, André Hemping-Bovenkerk, Julia Krasnyanska, Sören Torge Mees, Marina Kochetkova, Sandra Stoeppeler and Jörg Haie

Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial

Visceral leishmaniasis (VL) is a fatal parasitic disease with 500,000 new cases each year according to WHO estimates. New and better treatment options are urgently needed in disease endemic areas due to the long courses, toxicity and development of resistance to current treatments. Recently, the antibiotic paromomycin was tested and registered in India to treat this disease. The current study describes a clinical trial to test the effectiveness of injectable paromomycin, either alone or in combination with the standard drug sodium stibogluconate in three East African countries—Sudan, Kenya and Ethiopia. The study showed that at the same paromomycin dose that was successfully used and registered in India, a far poorer outcome was obtained, particularly in Sudan, suggesting that there are either differences in the patients ability to respond to the drug or in the susceptibility of parasites in East Africa compared with those in India. However, no major safety concerns were noted with the treatment. Further research was initiated to see if a higher dose of paromomycin would perform better, especially in Sudan. The results of this and the performance of the combination arm will be reported later. Our study highlights the importance of considering geographical differences to treatment responses